VPRIV (velaglucerase)

pCPA File Number: 21000
Negotiation Status:
Concluded with an LOI
Indication(s):
Gaucher disease
Sponsor/Manufacturer:
Shire Pharma Canada ULC
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: